Long-acting controlled formulations of contraceptives(DelsiTech)(Long-acting controlled formulations of contraceptives(DelsiTech))

概要

基本信息

药物类型

化学药

别名-

靶点-

作用方式-

作用机制-

治疗领域

其他疾病

在研适应症

避孕

非在研适应症-

原研机构

DelSiTech Oy

在研机构

DelSiTech Oy

非在研机构-

最高研发阶段临床前

首次获批日期-

最高研发阶段(中国)-

特殊审评-

关联

100 项与 Long-acting controlled formulations of contraceptives(DelsiTech) 相关的临床结果

登录后查看更多信息

100 项与 Long-acting controlled formulations of contraceptives(DelsiTech) 相关的转化医学

登录后查看更多信息

100 项与 Long-acting controlled formulations of contraceptives(DelsiTech) 相关的专利（医药）

登录后查看更多信息

1

项与 Long-acting controlled formulations of contraceptives(DelsiTech) 相关的文献（医药）

2015-03-12·The Nurse Practitioner

Primary care recommendations

Review

作者: Roncari, Danielle ; Atkin, Kathryn ; Beal, Margaret W ; Long-Middleton, Ellen

Long-acting reversible contraceptive (LARC) methods are underutilized in the adolescent population despite their superior efficacy over non-LARC methods. The purpose of this article is to discuss the barriers that lead to underutilization of these methods and present an evidence-based approach for the use of LARC methods among adolescents in the primary care setting.

100 项与 Long-acting controlled formulations of contraceptives(DelsiTech) 相关的药物交易

登录后查看更多信息